Why the study?
Does a lower dose of urokinase (2000 IU/kg/h) with heparin improve early revascularization compared to a higher dose of urokinase (4400 IU/kg/h) followed by heparin in patients with acute severe pulmonary embolism?
Does a lower dose of urokinase (2000 IU/kg/h) with heparin improve early revascularization compared to a higher dose of urokinase (4400 IU/kg/h) followed by heparin in patients with acute severe pulmonary embolism?
A lower dose of catheter-directed urokinase combined with heparin achieves similar angiographic resolution of severe pulmonary embolism compared to a higher dose of urokinase alone, with comparable bleeding risks.
Answers are grounded in this paper and cite their sources.
May support lower-dose urokinase plus heparin in acute PE; leaves open confirmation in larger randomized trials.
A multicentre trial (10 centres) of urokinase (UK) was performed in patients with acute severe pulmonary embolism (PE). The aim of this trial was, to compare the efficacy of two doses of UK administered via a catheter in the pulmonary artery: 2000 IU kg−1 h−1 for 24 hours (UK 2000) in conjunction with heparin versus 4400 IU kg−1 h−1 UK alone for 12 hours ( UK 4400) followed by heparin. PE was less than 5 days old and the clinical diagnosis was confirmed by pulmonary angiograms demonstrating a vascular obstruction of more than 30% (Miller‘s index >11). The efficacy of treatment was evaluated by the degree of early revascularization (pulmonary angiograms were performed 30 to 48 hours after initiation of thrombolytic treatment and analysed blindly by four independent vascular radiologists). 133 patients were included in this trial: two patients died before treatment and two were excluded retrospectively, leaving 129 patients for final analysis (67: UK 2000 + heparin; 62: UK 4400). The two groups had similar pretreatment clinical, haemodynamic andangiographic characteristics: the Miller angiographic index of severity averaged 22.6 ± 3.7 for patients in the UK 2000 group, and 22.6 ±3.4 for patients in the UK 4400 group (average filling defect of 66% on pulmonary angiograms). There was a similar and significant degree of resolution in the two groups: 26% and 20%, respectively. Minor and major bleeding problems were observed with equal frequency in the two groups (24% and 29%, respectively). These bleeding complications were severe in only 4.5% and 3%, respectively. We conclude that (1) effective thrombolysis with UK can be achieved without a loading dose and with half (2000 IU kg−1 h−1) the previously recommended intravenous hourly dose, (2) heparin, carefully controlled can be administered safely with the UK 2000 IU kg−1 h−1 dosage regimen and that (3) our data support a trend, which is not statistically significant, that greater emboli resolution can be obtained with an association of moderate doses of UK and heparin, for at least 24 hours.
No takes yet. Share an insight, caveat, or question.
A 1987 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: